Both in human sarcomas and bladder carcinomas stathmin is frequently upregulated in the early stages of tumor progression, as revealed by bioinformatic analyses using the Oncomine resource (Figure S1), suggesting that stathmin could be implicated in the onset of these types of cancer. Here, STMN1 is linked to urinary bladder carcinoma.